Amneal Pharmaceuticals (AMRX) Depreciation and Depletion (2017 - 2018)

Amneal Pharmaceuticals' (AMRX) quarterly Depreciation and Depletion came in at $18.6 million in Q4 2018, up 56.19% year-on-year from $11.9 million in Q4 2017, and up 7.25% quarter-over-quarter from $17.4 million in Q3 2018.

Amneal Pharmaceuticals (AMRX) Depreciation and Depletion (2017 - 2018) Analysis & Trends

Amneal Pharmaceuticals' Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $18.6 million for Q4 2018.

  • On a quarterly basis, Depreciation and Depletion rose 56.19% year-over-year to $18.6 million in Q4 2018; TTM through Dec 2018 was $63.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $57.3 million, down 8.47% from the prior year.
  • Depreciation and Depletion improved to $18.6 million in Q4 2018 per AMRX's latest filing, from $17.4 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $18.6 million in Q4 2018 and bottomed at $9.6 million in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 36.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 21.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 28.00 Mn
10 Amneal Pharmaceuticals 5.68 Bn 5.67 Bn 320.11 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 18.62 Mn
Dec 31, 2018 18.62 Mn
Sep 30, 2018 17.36 Mn
Sep 30, 2018 17.36 Mn
Jun 30, 2018 15.45 Mn
Jun 30, 2018 15.45 Mn
Dec 31, 2017 11.92 Mn
Dec 31, 2017 11.92 Mn
Sep 30, 2017 10.68 Mn
Sep 30, 2017 10.68 Mn
Jun 30, 2017 9.65 Mn
Jun 30, 2017 9.65 Mn